General Announcement::Orphan Drug Designation Granted for the Treatment of CRPS with Ketamine to iX Biopharma

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-May-2021 12:18:04
Status
New
Announcement Sub Title
Orphan Drug Designation Granted for the Treatment of CRPS with Ketamine to iX Biopharma
Announcement Reference
SG210517OTHR9XY7
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

Press Release - CRPS Orphan Drug Designation.pdf
Total size =226K